COVID-19 Chapter 7: Spillover

COVID-19 Chapter 7: Spillover

Coming at ya with our seventh episode in our Anatomy of a Pandemic series on the ongoing COVID-19 situation. So far in the series, we’ve discussed aspects of the virus’s biology, clinical disease, epidemiology, and control efforts. We’ve briefly touched on aspects of the virus’s ecology, including its origins, but we wanted to take a step back and ask, “how do spillover events happen and how do we stop them?” To answer those questions (and many more), we brought on Dr. Jonna Mazet, Professor of Epidemiology and Disease Ecology at the UC Davis School of Veterinary Medicine and Executive Director of the UC Davis One Health Institute, who has spent much of her professional life on the hunt for emerging pathogens (interview recorded April 2, 2020). We pick Dr. Mazet’s brain on how we look for and identify pathogens of possible public health concern, what work disease ecologists are currently doing on SARS-CoV-2, and what we can expect to see in terms of future spillover events. We wrap up the episode by discussing the top five things we learned from our expert. To help you get a better idea of the topics covered in this episode, we have listed the questions below:

  1. Can you take us through a step-by-step of how surveillance of novel pathogens is done? From the logistics of international coordination to the sampling to the reporting - what does that look like?
  2. What happens when you do identify a potential spillover event?
  3. Can you talk about how you decide what a hotspot is? What makes a hotspot a hotspot basically?
  4. We've talked a lot on this podcast about spillover events, and obviously they can happen in many different ways, but can you give us a general overview of how one occurs? What are some patterns we see with all spillover events?
  5. Over the past 100, 200 years, land use change has increased and the barrier between humans and wildlife has decreased - have we seen a corresponding increase in spillover events during that time?
  6. What do we know at this point about how SARS-CoV-2 spilled over into humans?
  7. I assume eventually we will get a clearer picture of how that spillover event occurred. How can we use that information in the future?
  8. Can you talk about what it means for a pathogen to "jump species"? Do viruses more easily "jump species" compared to bacteria, or is it just that we hear more about the viruses?
  9. I'd like to talk about what happens when prevention has to shift to control. What are the first steps taken for disease ecologists studying this outbreak? How is the One Health approach being used to study and slow down the current COVID-19 pandemic?
  10. What role do we see wildlife conservation playing in spillover events or preventing them? Can you talk about how there can be a conflict in wildlife conservation for the greater good when people are also just trying to feed their families?
  11. How do you determine whether something easily moves between species? Is that a genomic question or is it an experimental question?
  12. What do you think are some of the biggest barriers or challenges in identifying these spillover events in the future?
  13. The One Health approach is such a great example of interdisciplinary collaboration. Can you talk about what some of the different fields are that work in One Health?
  14. What positive changes do you hope to see come out of this pandemic?


Follow Dr. Jonna Mazet (@JonnaMazet), the PREDICT project (@PREDICTproject), and the Global Virome Project (@GlobalVirome). Or check out their websites: One Health Institute (https://ohi.vetmed.ucdavis.edu/), PREDICT (http://data.predict.global/), Global Virome Project (www.globalviromeproject.org).

The firsthand account was taken from a piece by Craig Spencer, MD written for the Washington Post titled, “How long will we doctors last?”

See omnystudio.com/listener for privacy information.

Episoder(282)

Special Episode: Adam Kucharski & Proof

Special Episode: Adam Kucharski & Proof

Why do we believe what we believe? Is what we believe the truth? How can we convince others of our beliefs? If you’ve ever found yourself pondering these questions, you know that the answers are rarel...

21 Apr 50min

Ep 207 Tear Gas: How can a chemical weapon be “humane”?

Ep 207 Tear Gas: How can a chemical weapon be “humane”?

Tear gas is an expected, normalized part of protests today. But its use in international war is banned. How can that be? That’s just one of the questions we investigate in this episode. First, we take...

14 Apr 1h 15min

Ep 206 Oropouche Virus: More than a smidge worrisome

Ep 206 Oropouche Virus: More than a smidge worrisome

Though discovered relatively recently, Oropouche virus has been making headlines as an emerging vector-borne infectious disease on the rise. Not transmitted by the usual suspects (like ticks and mosqu...

7 Apr 1h 12min

Ep 205 Cancer Part 4: Where do things stand today?

Ep 205 Cancer Part 4: Where do things stand today?

For the entirety of our species’ history, our approach to cancer has largely been to react, to design new therapies and better combinations of treatments. This energy has certainly been well-spent, bu...

31 Mar 1h 19min

Ep 204 Cancer Part 3: How do we treat it?

Ep 204 Cancer Part 3: How do we treat it?

A century and a half ago, the list of effective cancer treatments was essentially a single entry: surgery. Today, in 2026, you’d need pages to contain the number of treatments available, and multiple ...

24 Mar 1h 32min

Special Episode: Lawrence Ingrassia & A Fatal Inheritance

Special Episode: Lawrence Ingrassia & A Fatal Inheritance

For centuries, physicians noticed that cancer sometimes ran in families, but until the 1960s, an answer to this mystery remained out of reach. Only then were scientists beginning to unlock the cellula...

17 Mar 45min

Ep 203 Cancer Part 2: Why does it happen?

Ep 203 Cancer Part 2: Why does it happen?

Each of our cells can become cancerous. It’s an uncomfortable, yet unavoidable truth. Nor is it a truth restricted to our species - cancer is a consequence of complex life. The features that make a ce...

10 Mar 1h 18min

Ep 202 Cancer Part 1: What is it?

Ep 202 Cancer Part 1: What is it?

Cancer has touched every one of us in some capacity, and learning of a diagnosis inspires many more questions than it answers. In this four-part series on cancer, we aim to lay a foundation of knowled...

3 Mar 1h 36min

Populært innen Vitenskap

fastlegen
jss
tingenes-tilstand
rekommandert
sinnsyn
forskningno
liberal-halvtime
tomprat-med-gunnar-tjomlid
rss-paradigmepodden
rss-nysgjerrige-norge
villmarksliv
kvinnehelsepodden
fjellsportpodden
nevropodden
nordnorsk-historie
rss-overskuddsliv
rss-rekommandert
diagnose
rss-bondevennen
psykopoden